Fingerprint
Dive into the research topics of 'Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study
Stephen A. Harrison*, Federico Perez Manghi, William B. Smith, Diana Alpenidze, Diego Aizenberg, Naomi Klarenbeek, Chi Yi Chen, Eli Zuckerman, Eric Ravussin, Phunchai Charatcharoenwitthaya, Pin Nan Cheng, Helena Katchman, Samuel Klein, Ziv Ben-Ari, Anisha E. Mendonza, Yiming Zhang, Miljen Martic, Shenglin Ma, Sheena Kao, Sandra Tanner
*Corresponding author for this work
- Pinnacle Clinical Research
- CINME
- University of Tennessee Health Science Center
- City Outpatient Clinic #117
- Centro Médico Viamonte
- Center for Human Drug Research
- Chia-Yi Christian Hospital
- Carmel Medical Center
- LSU Pennington Biomedical Research Center
- Mahidol University
- National Cheng Kung University
- Tel Aviv Sourasky Medical Center
- Washington University St. Louis
- Sheba Medical Center at Tel Hashomer
- Novartis USA
- Novartis
- Novartis Institutes for Biomedical Research
- Altasciences Algorithme Pharma
Research output: Contribution to journal › Article › peer-review
47
Scopus
citations